Spark Media Solutions, LLC

sparkmediasolutions.com

B2B content marketing agency for the tech industry. Content marketers that have perfected the model of building influencer relations through content. When dedicated to building an editorial voice, our clients have become the leading corporate media brand for their industry. We've worked with companies such as HP, IBM, Oracle, Microsoft, Juniper Networks, Symantec, Indycar, LinkedIn, Citrix, IDG, Dice, and many more. Our most popular service is live event reporting and production.

C-Suite On Deck

David Spark, Content Marketer and Producer, Managing Editor at Spark Media Solutions is a veteran tech journalist and founder of Spark Media Solutions. He’s been the creative director, producer, voice, and face of many content marketing campaigns for a number of Fortune 1000 B2B te...

Events

Related News

INDUSTRIAL IMPACT, MEDICAL

KYMANOX ANNOUNCES ACQUISITION OF ANTERIS MEDICAL AND ANTERIS HELVETIA

Kymanox | February 06, 2023

news image

Kymanox, a leading life science-focused professional services firm, recently announced the acquisition of anteris medical GmbH and anteris helvetia AG (collectively anteris). Anteris specializes in assisting the commercialization and development of medical equipment, combination and in-vitro diagnostic products. This acquisition enables both firms to achieve their common organizational goal of geographic expansion while enhancing their service capabilities by offering clients a ...

Read More

INDUSTRY OUTLOOK

PUMA BIOTECH PUBLISHES ALISERTIB PHASE II TRIAL RESULTS IN JAMA ONCOLOGY

Puma Biotechnology, Inc. | March 16, 2023

news image

Puma Biotechnology, Inc., a biopharmaceutical company, recently announced the online publication of the Phase II TBCRC041 randomized clinical trial results in JAMA Oncology. The trial investigated the use of alisertib, an adenosine triphosphate–competitive and reversible inhibitor of aurora kinase A, alone or in combination with fulvestrant in postmenopausal women with endocrine-resistant, HER2-negative metastatic breast cancer who were previously treated with fulvestrant. ...

Read More

INDUSTRIAL IMPACT, MEDICAL

ELEMENTAL MACHINES PARTNERS WITH SYSTEM-C BIOPROCESS TO BRING ITS IOT HARDWARE SOLUTIONS TO THE EUROPEAN BIOPHARMACEUTICAL INDUSTRY

Prnewswire | March 30, 2023

news image

Elemental Machines, developer of the Intelligent Operations Platform, has entered into a partnership with System-c bioprocess as an authorized reseller of Elemental Machines' hardware solutions, servicing the biopharmaceutical industry in France. The partnership will allow Elemental Machines to expand its footprint further in European markets. System-c serves as a partner and distributor for benchmark brands that cover a range of bioprocessing products from screening to filt...

Read More

MEDICAL

TRIALSPARK, COMMITTS TO IMPROVE SPEED, QUALITY, AND INNOVATION OF CLINICAL TRIALS, ANNOUNCES COLLABORATION WITH ADITUM BIO

TrialSpark | December 21, 2020

news image

TrialSpark, a tech-enabled drug development accomplice focused on improving the speed, quality, and innovation of clinical trials, officially announces a collaboration with Aditum Bio, a San Francisco-based venture endeavor firm engaged with respect to getting and creating biotechnology resources that will benefit patients. Anteris Bio in-licensed ANT-401 from vTv Therapeutics, to be studied in CKD and across multiple etiologies of renal diseases. As Aditum Bio's drug developm...

Read More
news image

INDUSTRIAL IMPACT, MEDICAL

KYMANOX ANNOUNCES ACQUISITION OF ANTERIS MEDICAL AND ANTERIS HELVETIA

Kymanox | February 06, 2023

Kymanox, a leading life science-focused professional services firm, recently announced the acquisition of anteris medical GmbH and anteris helvetia AG (collectively anteris). Anteris specializes in assisting the commercialization and development of medical equipment, combination and in-vitro diagnostic products. This acquisition enables both firms to achieve their common organizational goal of geographic expansion while enhancing their service capabilities by offering clients a ...

Read More
news image

INDUSTRY OUTLOOK

PUMA BIOTECH PUBLISHES ALISERTIB PHASE II TRIAL RESULTS IN JAMA ONCOLOGY

Puma Biotechnology, Inc. | March 16, 2023

Puma Biotechnology, Inc., a biopharmaceutical company, recently announced the online publication of the Phase II TBCRC041 randomized clinical trial results in JAMA Oncology. The trial investigated the use of alisertib, an adenosine triphosphate–competitive and reversible inhibitor of aurora kinase A, alone or in combination with fulvestrant in postmenopausal women with endocrine-resistant, HER2-negative metastatic breast cancer who were previously treated with fulvestrant. ...

Read More
news image

INDUSTRIAL IMPACT, MEDICAL

ELEMENTAL MACHINES PARTNERS WITH SYSTEM-C BIOPROCESS TO BRING ITS IOT HARDWARE SOLUTIONS TO THE EUROPEAN BIOPHARMACEUTICAL INDUSTRY

Prnewswire | March 30, 2023

Elemental Machines, developer of the Intelligent Operations Platform, has entered into a partnership with System-c bioprocess as an authorized reseller of Elemental Machines' hardware solutions, servicing the biopharmaceutical industry in France. The partnership will allow Elemental Machines to expand its footprint further in European markets. System-c serves as a partner and distributor for benchmark brands that cover a range of bioprocessing products from screening to filt...

Read More
news image

MEDICAL

TRIALSPARK, COMMITTS TO IMPROVE SPEED, QUALITY, AND INNOVATION OF CLINICAL TRIALS, ANNOUNCES COLLABORATION WITH ADITUM BIO

TrialSpark | December 21, 2020

TrialSpark, a tech-enabled drug development accomplice focused on improving the speed, quality, and innovation of clinical trials, officially announces a collaboration with Aditum Bio, a San Francisco-based venture endeavor firm engaged with respect to getting and creating biotechnology resources that will benefit patients. Anteris Bio in-licensed ANT-401 from vTv Therapeutics, to be studied in CKD and across multiple etiologies of renal diseases. As Aditum Bio's drug developm...

Read More

Resources

Events

C-Suite On Deck

David Spark, Content Marketer and Producer, Managing Editor at Spark Media Solutions is a veteran tech journalist and founder of Spark Media Solutions. He’s been the creative director, producer, voice, and face of many content marketing campaigns for a number of Fortune 1000 B2B te...